Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Author and illustrator S. F. Craftlove offers a clever illustrated collection for readers who like their books strange, funny, and impossible to forget.
Author Larry Patzer Brings Depth and Discussion to Modern Fiction
C.M. Patterson Releases Never Alone, a Powerful Short Story Collection About Mental Health, Trauma, and Recovery
LM Electronics Issues Induction Cooker Buying Guidance for Bangladesh Households
BuzzVoice Introduces Comment Likes for YouTube and Instagram
Indonesia Maintains Strong Position in Global Professional Dive Training
The Role of Instructor Evaluations in Professional Dive Education
Why Small Island Training Environments Remain Popular for Instructor Development
Gili Trawangan Continues to Attract International Divemasters Seeking Instructor Certification
Full Scale Marks Continued Growth as Demand for Offshore Software Staffing Expands
Chengdu opens first direct air cargo route to Africa
A New Chatbot Wants to Unlock the Secrets in Tattered Ancient Greek Records
White hats outrun Coldcard hackers in 52-Bitcoin evacuation
US satellite maker Planet Labs opens Berlin factory as military demand booms
How to Use AI With Your Privacy Intact
BTN EXCLUSIVE: Inside Etihad’s vision for the future at Arabian Travel Market
Crypto’s wild boom-and-bust cycles are fading, Solstice CEO says
Apricoin Focuses on Practical Access to Digital Asset Markets
From the best and worst companies to how to get treated fairly – ask our consumer champion anything
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute